The dietary supplement’s published ingredient list includes magnesium glycinate, alpha-lipoic acid, butcher’s broom, L-carnitine, turmeric and Coenzyme Q10. Individual ingredient quantities and product-specific clinical trial evidence have not been publicly established. Los Angeles, California — Quiet Nerves has published an overview of its six-ingredient dietary supplement formula, identifying magnesium glycinate, alpha-lipoic acid, butcher’s broom, L-carnitine, […]
The dietary supplement’s published ingredient list includes magnesium glycinate, alpha-lipoic acid, butcher’s broom, L-carnitine, turmeric and Coenzyme Q10. Individual ingredient quantities and product-specific clinical trial evidence have not been publicly established.
Los Angeles, California — Quiet Nerves has published an overview of its six-ingredient dietary supplement formula, identifying magnesium glycinate, alpha-lipoic acid, butcher’s broom, L-carnitine, turmeric standardized to 95% curcuminoids and Coenzyme Q10 as its listed ingredients.
The disclosure provides consumers with the names and general descriptions of the six ingredients. However, the published information does not provide individual quantities for the ingredients, making it difficult to compare the formula directly with doses examined in scientific studies.
The distinction is important because research on individual nutrients and botanical extracts does not automatically establish the effectiveness of a finished supplement containing those ingredients.
The product’s published information describes Quiet Nerves as a daily capsule intended for nutritional support. It also discusses research associated with nerve function, antioxidant activity and circulation. Those descriptions should be considered separately from evidence demonstrating whether the complete formula produces a particular health outcome.
What Ingredients Does Quiet Nerves Contain?
Quiet Nerves identifies six ingredients: magnesium glycinate, alpha-lipoic acid, butcher’s broom, L-carnitine, turmeric standardized to 95% curcuminoids and Coenzyme Q10.
The ingredients represent different categories of nutrients and plant-derived compounds. Their presence on a product information page does not establish that each has been clinically demonstrated to improve nerve health in the amount or combination used in this formula.
The six listed ingredients are:
-
Magnesium glycinate: A form of magnesium bound to glycine.
-
Alpha-lipoic acid: An antioxidant compound also known as thioctic acid.
-
Butcher’s broom: A botanical derived from Ruscus aculeatus.
-
L-carnitine: A compound involved in transporting fatty acids into mitochondria.
-
Turmeric: A plant extract described by the brand as standardized to 95% curcuminoids.
-
Coenzyme Q10: A naturally occurring compound involved in cellular energy production.
The published ingredient overview does not provide individual milligram quantities for these six ingredients. It also does not establish that the finished Quiet Nerves formula has undergone a controlled clinical trial.
See what makes Quiet Nerves’s ingredient blend interesting.
Why Ingredient Quantities Matter in Supplement Research
The amount of an ingredient can influence whether a commercial supplement can reasonably be compared with a scientific study.
Clinical trials generally specify the preparation, quantity, duration and population being studied. A supplement label that identifies an ingredient without providing its quantity does not allow consumers to determine whether the product contains an amount comparable to those used in research.
For example, studies of alpha-lipoic acid have examined hundreds of milligrams per day. Research involving acetyl-L-carnitine has also used quantities measured in hundreds or thousands of milligrams.
Those findings cannot establish the amount present in Quiet Nerves.
The distinction is especially relevant when a product lists ingredients with different chemical forms. Plain L-carnitine, for example, is not identical to acetyl-L-carnitine, the form used in several nerve-related clinical studies.
A transparent ingredient list is useful, but ingredient names alone do not provide the complete information needed to evaluate a formulation.
Magnesium Glycinate and Neuromuscular Function
Magnesium is an essential mineral involved in hundreds of processes in the human body, including normal muscle and nerve function.
Magnesium glycinate is a form in which magnesium is bound to glycine. The National Institutes of Health Office of Dietary Supplements (NIH ODS) explains that magnesium contributes to normal nerve transmission, muscle contraction and other physiological functions.
However, evidence that magnesium is essential for normal nerve activity is not the same as evidence that a particular magnesium supplement improves nerve-related symptoms.
Research examining magnesium and nerve health has included observational studies and investigations using different magnesium preparations. These findings cannot automatically be applied to magnesium glycinate in Quiet Nerves.
The amount of magnesium in a serving is also relevant. Because the product information does not establish the individual magnesium quantity, consumers cannot directly compare its formulation with a specific research dose.
The NIH ODS notes that high supplemental magnesium intake can cause diarrhea, nausea and abdominal cramping. People with impaired kidney function may face a greater risk of magnesium accumulation.
Alpha-Lipoic Acid: What Human Studies Have Examined
Alpha-lipoic acid, also called ALA or thioctic acid, is an antioxidant compound that participates in cellular energy metabolism.
It has been investigated in human studies involving diabetic peripheral neuropathy, a condition associated with nerve damage in people with diabetes.
One frequently cited investigation is the SYDNEY 2 trial, published in 2006. The randomized, double-blind study included 181 people with diabetic peripheral neuropathy who received oral alpha-lipoic acid at doses of 600 mg, 1,200 mg or 1,800 mg daily, or placebo, for five weeks.
The researchers reported improvements in symptom scores in the alpha-lipoic acid groups compared with placebo. The 600 mg dose produced a similar overall symptom reduction to the higher doses during the study period.
However, this was research involving a specific ingredient, dose and patient population. It was not a trial of Quiet Nerves.
The findings also do not establish that an undisclosed amount of alpha-lipoic acid in a commercial supplement would produce the same outcome.
Butcher’s Broom and Research on Circulation
Butcher’s broom (Ruscus aculeatus) is a botanical traditionally used in preparations associated with circulation and lower-leg discomfort.
Human research has examined certain butcher’s broom extracts in people with chronic venous insufficiency, a condition involving impaired blood flow through the veins.
A randomized, double-blind, placebo-controlled trial published in 2002 included women with chronic venous insufficiency. Researchers investigated a specific Ruscus extract over 12 weeks and reported differences in leg volume and certain symptoms compared with placebo.
The study concerned venous circulation and leg symptoms. It did not demonstrate that butcher’s broom improves nerve function or treats neuropathy.
The preparation used in a clinical trial also cannot automatically be equated with the botanical ingredient listed in Quiet Nerves. The extract specification and quantity would need to be known before a meaningful comparison could be made.
This distinction matters when botanical ingredients appear in products marketed around more than one area of health.
L-Carnitine and Acetyl-L-Carnitine Are Not the Same Form
L-carnitine is a naturally occurring compound involved in transporting long-chain fatty acids into mitochondria, where cells produce energy.
Research involving nerve symptoms has frequently examined acetyl-L-carnitine rather than ordinary L-carnitine. Although the compounds are related, they are not interchangeable when interpreting clinical findings.
A Cochrane review published in 2019 assessed acetyl-L-carnitine for diabetic peripheral neuropathy. It included four trials involving more than 900 participants.
The review concluded that the evidence was uncertain about whether acetyl-L-carnitine reduces neuropathic pain. The researchers also noted limitations in the available studies and the low or very low certainty of some findings.
Quiet Nerves lists L-carnitine. The available product information does not establish that it contains acetyl-L-carnitine.
Therefore, results from trials using the acetyl form should not be presented as proof of an effect from the L-carnitine listed in the product.
Turmeric and Curcuminoid Research
Turmeric (Curcuma longa) contains naturally occurring compounds called curcuminoids, including curcumin.
Quiet Nerves’ published ingredient information describes its turmeric as standardized to 95% curcuminoids. That percentage describes the stated standardization of the extract; it does not disclose how many milligrams of turmeric extract are included in a serving.
Research on curcumin has explored inflammatory pathways and several health-related outcomes. Some studies have also examined specialized curcumin preparations in people with diabetic peripheral neuropathy.
A 2025 randomized, double-blind clinical trial investigated nanocurcumin in people with type 2 diabetes and diabetic peripheral neuropathy. Participants received 40 mg twice daily or placebo over 16 weeks.
The researchers found no statistically significant differences between the groups in the principal neuropathy outcomes at the end of the study.
The study examined nanocurcumin, not necessarily the same preparation described in Quiet Nerves’ product information. A 95% curcuminoid standardization does not establish that an ingredient is nanocurcumin.
Consequently, the results of this trial cannot be used as evidence that Quiet Nerves improves neuropathy.
Coenzyme Q10 and Cellular Energy Production
Coenzyme Q10, commonly called CoQ10, is a compound produced naturally by the body. It plays a role in mitochondrial energy production and also functions as an antioxidant.
Researchers have investigated CoQ10 in several areas of health, including cardiovascular function, metabolic health and diabetic complications.
A 2014 randomized clinical trial examined CoQ10 supplementation in 70 people with type 2 diabetes and neuropathic signs. Participants received 200 mg daily or placebo for 12 weeks.
The study reported changes in certain measures related to oxidative stress and inflammation. However, neuropathic symptoms and electromyography measurements did not differ significantly between the groups after treatment.
This finding is important because changes in laboratory markers do not necessarily translate into improvements in nerve symptoms.
The study also examined a specified dose of CoQ10 as an individual intervention. It did not evaluate the six-ingredient Quiet Nerves formula.
Curious about Quiet Nerves’s ingredient combination? Explore more.
What Is Known About Quiet Nerves Clinical Testing?
The available product information identifies six ingredients but does not establish that the finished Quiet Nerves formula has been evaluated in a controlled clinical trial.
Research involving individual ingredients should not be described as a clinical trial of the complete supplement.
A product-specific trial would need to identify the complete formulation, participant population, study duration, comparison group and measured outcomes. Those details would help determine whether any reported result applies to the finished product.
Until such evidence is made available, statements about Quiet Nerves itself should remain limited to verified formulation information and the research background of its listed ingredients.
Proposed Product Formulator Quote
“Ingredient selection is only one part of supplement formulation. The amount, chemical form and supporting research for each ingredient are also important when evaluating how a finished product is described. Consumers should be able to distinguish research conducted on individual ingredients from studies that specifically evaluate a complete formula.”
Tate Lerry ,Product Formulator, Quiet Nerves
Dietary Supplement Regulation and Consumer Information
Dietary supplements are regulated differently from prescription medicines in the United States. The FDA does not approve dietary supplements for safety and effectiveness before they are marketed.
Manufacturers and distributors are responsible for complying with applicable requirements, including those concerning product safety, labeling and claims.
Consumers should review the complete Supplement Facts panel, serving instructions, other ingredients and warning statements before using a supplement.
People who take prescription medication, have an existing medical condition, are pregnant or breastfeeding, or are preparing for surgery should consult a qualified healthcare professional before starting a new supplement.
Quiet Nerves’ published website includes the standard disclaimer that its statements have not been evaluated by the FDA and that the product is not intended to diagnose, treat, cure or prevent disease.
Explore what makes Quiet Nerves’s formula unique.
Frequently Asked Questions About Quiet Nerves
What is Quiet Nerves?
Quiet Nerves is a dietary supplement marketed as a daily capsule. Its published ingredient information identifies six ingredients associated with nutritional, antioxidant and botanical research.
What are the six ingredients in Quiet Nerves?
The six listed ingredients are magnesium glycinate, alpha-lipoic acid, butcher’s broom, L-carnitine, turmeric standardized to 95% curcuminoids and Coenzyme Q10.
Does Quiet Nerves disclose individual ingredient quantities?
The published ingredient information reviewed for this announcement does not provide individual milligram quantities for the six ingredients. Consumers should consult the complete current product label for serving-specific amounts.
Does alpha-lipoic acid have human research behind it?
Yes. The SYDNEY 2 trial investigated oral alpha-lipoic acid in people with diabetic peripheral neuropathy. Its findings relate to the tested doses and study population, not automatically to Quiet Nerves.
Is L-carnitine the same as acetyl-L-carnitine?
No. They are related compounds but different forms. Several nerve-related studies examined acetyl-L-carnitine rather than the L-carnitine listed by Quiet Nerves.
Has butcher’s broom been studied in humans?
Yes. A randomized trial investigated a specific butcher’s broom extract in women with chronic venous insufficiency. That research focused on leg symptoms and venous circulation, not treatment of neuropathy.
Does turmeric research prove that Quiet Nerves improves nerve health?
No. Research on specialized curcumin preparations cannot automatically be applied to a different turmeric extract or to the finished Quiet Nerves formula.
Has the complete Quiet Nerves formula been clinically tested?
The product information reviewed for this announcement does not provide evidence of a controlled clinical trial involving the finished six-ingredient formula.
Is Quiet Nerves FDA-approved?
No FDA approval has been established. The FDA does not approve dietary supplements for safety and effectiveness before they are marketed.
Can Quiet Nerves replace prescribed treatment?
No. A dietary supplement should not replace prescribed medication, professional medical advice or evaluation of new or worsening symptoms.
About Quiet Nerves
Quiet Nerves is presented by its website as a dietary supplement in capsule form. Its published ingredient overview identifies magnesium glycinate, alpha-lipoic acid, butcher’s broom, L-carnitine, turmeric and Coenzyme Q10. Further company background, founding information and corporate mission details were not independently established in the information reviewed for this announcement.
Media Contact
Company: Quiet Nerves
Media contact person: Henry Lame
Email: cs@quietnerves.com
Phone: +18042584129
Website: Quietnerves.com
